TJC, tender joint count

A randomised comparative study of the short term clinical and biological effects of intravenous pulse methylprednisolone and infliximab in patients with active rheumatoid arthritis despite methotrexate treatment
P Durez, A Nzeusseu Toukap, B R Lauwerys, D H Manicourt, P Verschueren, R Westhovens, J-P Devogelaer, F A Houssiau

Annals of the Rheumatic Diseases Sep 2004, 63 (9) 1069-1074; DOI: 10.1136/ard.2003.012914
Long term efficacy and safety of adalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study
M E Weinblatt, E C Keystone, D E Furst, A F Kavanaugh, E K Chartash, O G Segurado

Annals of the Rheumatic Diseases Jun 2006, 65 (6) 753-759; DOI: 10.1136/ard.2005.044404
True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin α?
M H Buch, P G Conaghan, M A Quinn, S J Bingham, D Veale, P Emery

Annals of the Rheumatic Diseases Oct 2004, 63 (10) 1344-1346; DOI: 10.1136/ard.2003.014878
Comparing the long-term clinical outcome of treatment with methotrexate or sulfasalazine prescribed as the first disease-modifying antirheumatic drug in patients with inflammatory polyarthritis
S L Hider, A Silman, D Bunn, S Manning, D Symmons, M Lunt

Annals of the Rheumatic Diseases Nov 2006, 65 (11) 1449-1455; DOI: 10.1136/ard.2005.049775

Main menu